Emily Von Scheven

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, 505 Parnassus Avenue, Box 0105, San Francisco, CA, 94143, USA
    Curr Osteoporos Rep 12:289-99. 2014
  2. pmc The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center
    Aimee O Hersh
    Department of Pediatrics, Division of Rheumatology, University of California, San Francisco, USA
    Pediatr Rheumatol Online J 7:13. 2009
  3. ncbi Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability
    Emily Von Scheven
    Pediatric Rheumatology, University of California San Francisco, 533 Parnassus Avenue, Box 0107, San Francisco, CA 94143, USA
    Arthritis Rheum 49:862-5. 2003
  4. pmc Vitamin D supplementation in the pediatric rheumatology clinic
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, Box 0107, 533 Parnassus Avenue, Room U 126, San Francisco, CA 94143, USA
    Curr Rheumatol Rep 13:110-6. 2011
  5. ncbi What's new in paediatric SLE?
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, CA 94143, USA
    Best Pract Res Clin Rheumatol 23:699-708. 2009
  6. ncbi Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies
    E von Scheven
    Pediatric Rheumatology, University of California, San Francisco, CA 94143, USA
    Lupus 14:440-4. 2005
  7. pmc Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study
    Emily Von Scheven
    Children s Hospital, University of California at San Francisco, 94143, USA
    J Pediatr Endocrinol Metab 19:821-30. 2006
  8. ncbi Pediatric bone density and fracture
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, Box 0107, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    Curr Osteoporos Rep 5:128-34. 2007
  9. pmc Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus
    Aimee O Hersh
    University of California, San Francisco, CA, USA
    Arthritis Rheum 61:13-20. 2009
  10. ncbi Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome
    Emily Von Scheven
    Pediatric Rheumatology, University of California at San Francisco, 94143, USA
    Arthritis Rheum 47:414-20. 2002

Research Grants

  1. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2001
  2. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2002
  3. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2003
  4. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2004
  5. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2005

Collaborators

Detail Information

Publications17

  1. ncbi Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, 505 Parnassus Avenue, Box 0105, San Francisco, CA, 94143, USA
    Curr Osteoporos Rep 12:289-99. 2014
    ....
  2. pmc The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center
    Aimee O Hersh
    Department of Pediatrics, Division of Rheumatology, University of California, San Francisco, USA
    Pediatr Rheumatol Online J 7:13. 2009
    ..The purpose of this study is to examine changes in disease status, treatment and health care utilization among adolescents transferring to adult care at the University of California San Francisco (UCSF)...
  3. ncbi Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability
    Emily Von Scheven
    Pediatric Rheumatology, University of California San Francisco, 533 Parnassus Avenue, Box 0107, San Francisco, CA 94143, USA
    Arthritis Rheum 49:862-5. 2003
  4. pmc Vitamin D supplementation in the pediatric rheumatology clinic
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, Box 0107, 533 Parnassus Avenue, Room U 126, San Francisco, CA 94143, USA
    Curr Rheumatol Rep 13:110-6. 2011
    ....
  5. ncbi What's new in paediatric SLE?
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, CA 94143, USA
    Best Pract Res Clin Rheumatol 23:699-708. 2009
    ..Better understanding of the pathogenesis and development of preventative strategies is needed to ensure that these young people do not succumb to atherosclerosis instead of to SLE...
  6. ncbi Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies
    E von Scheven
    Pediatric Rheumatology, University of California, San Francisco, CA 94143, USA
    Lupus 14:440-4. 2005
    ..Neither novel exon 7 beta2GPI mutations or the previously described C306G polymorphism was identified in this pediatric cohort...
  7. pmc Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study
    Emily Von Scheven
    Children s Hospital, University of California at San Francisco, 94143, USA
    J Pediatr Endocrinol Metab 19:821-30. 2006
    ..To evaluate the relationship between chronic glucocorticoid (GC) exposure and bone mineral density (BMD) in children with rheumatic diseases and inflammatory bowel disease...
  8. ncbi Pediatric bone density and fracture
    Emily Von Scheven
    Pediatric Rheumatology, University of California, San Francisco, Box 0107, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    Curr Osteoporos Rep 5:128-34. 2007
    ..However, most of these agents have not been sufficiently well studied in children to permit the development of standardized treatment guidelines...
  9. pmc Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus
    Aimee O Hersh
    University of California, San Francisco, CA, USA
    Arthritis Rheum 61:13-20. 2009
    ..To compare differences in long-term outcome between adults with childhood-onset (age at diagnosis <18 years) systemic lupus erythematosus (SLE) and with adult-onset SLE...
  10. ncbi Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome
    Emily Von Scheven
    Pediatric Rheumatology, University of California at San Francisco, 94143, USA
    Arthritis Rheum 47:414-20. 2002
    ..To determine whether serum beta2-glycoprotein I antibody (anti-beta2GPI) detection improves identification of pediatric subjects at risk for antiphospholipid syndrome (APS)...
  11. ncbi Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease
    Renee Modica
    University of California San Francisco, San Francisco, CA 94143, USA
    Arthritis Rheum 55:823-5. 2006
  12. pmc Assessment of bone remodelling in childhood-onset systemic lupus erythematosus
    Julie C Baker-Lepain
    Department of Medicine, University of California, San Francisco, CA, USA
    Rheumatology (Oxford) 50:611-9. 2011
    ..To identify predictors of bone remodelling in children and young adults with SLE...
  13. pmc Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey
    Erica F Lawson
    Department of Pediatrics, Division of Rheumatology and Immunology, University of California, San Francisco, 533 Parnassus, Rm U 127, Box 0107, San Francisco, CA 94143, USA
    Pediatr Rheumatol Online J 9:35. 2011
    ..abstract:..
  14. ncbi Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases
    Christine Kilcline
    Department of Dermatology, University of California, San Francisco 94143 0316, USA
    Arch Dermatol 141:248-53. 2005
    ....
  15. ncbi Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies
    Liora Harel
    Department of Pediatrics C, Schneider Children s Medical Center of Israel, Petach Tikvah, Israel
    J Rheumatol 33:1873-7. 2006
    ....
  16. ncbi Back to school on APS: rethinking the risk of recurrent stroke in children
    Heather J Fullerton
    Neurology 62:172-3. 2004
  17. ncbi Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus
    Jennifer B Soep
    University of Colorado School of Medicine, Denver, USA
    Arthritis Rheum 51:451-7. 2004
    ..To characterize atherosclerotic risk factors and endothelial function in pediatric-onset systemic lupus erythematosus (SLE)...

Research Grants5

  1. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2001
    ..Furthermore, development of this well characterized SLE cohort will serve as an important future resource and builds a foundation for studying many lifelong effects of childhood-onset SLE. ..
  2. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2002
    ..Furthermore, development of this well characterized SLE cohort will serve as an important future resource and builds a foundation for studying many lifelong effects of childhood-onset SLE. ..
  3. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2003
    ..Furthermore, development of this well characterized SLE cohort will serve as an important future resource and builds a foundation for studying many lifelong effects of childhood-onset SLE. ..
  4. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2004
    ..Furthermore, development of this well characterized SLE cohort will serve as an important future resource and builds a foundation for studying many lifelong effects of childhood-onset SLE. ..
  5. MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
    Emily Von Scheven; Fiscal Year: 2005
    ..Furthermore, development of this well characterized SLE cohort will serve as an important future resource and builds a foundation for studying many lifelong effects of childhood-onset SLE. ..